Bourbouli et al. found increased TDP-43 and tau levels in both ALS and FTD compared to healthy controls, and propose a combined index with TDP-43, tau and p-tau181 to improve data dispersion and increase discrimination between ALS-FTD spectrum and healthy controls [67]. The gene discussed is MAPT; the disease is frontotemporal dementia.